Volume 1
The extra pharmacopœia of Martindale and Westcott.
- William Martindale
- Date:
- 1932-1935
Licence: Public Domain Mark
Credit: The extra pharmacopœia of Martindale and Westcott. Source: Wellcome Collection.
1068/1272 page 1016
![of the true nature and origin of the substance, as may be prescribed shal] appear on the label. Date of manufacture shall be stated on all vessels or packages, and the sale is prohibited after the expiry of the prescribed period. Contravention of the Act renders a person liable on summary conviction to a line not exceeding £100, and on second or subsequent convic¬ tions to a fine and imprisonment with or without hard labour for not exceeding 3 months, and in either case goods to be forfeited and licence may be revoked or suspended. 7.—(1) The licensing authorities are for England and Wales, the Minister of Health : for Scotland, the Scottish Board of Health : for Northern Ireland, the Minister of Home Affairs for Northern Ireland. THERAPEUTIC SUBSTANCES REGULATIONS 1931, No. 633. PART I. Interpretation, etc. Addition of sterilized surgical ligature and suture to the 1925 Act. PART II. Licences for Manufacture of Therapeutic Substances. 6. —Applicant to satisfy the licensing authority that upon issue or renewal of licence the conditions set out in No. 7 of the Regulations will be observed. 7. —(a) Concerns provision of adequate staff and premises for manufacture (6) And for tests of the strength, quality and purity of the substance including housing for animals used, the licensee shall maintain staff and premises to carry out tests or make arrangements with some institution approved for such tests to be regularly carried out on Ills behalf. (c) Records of manufacture and tests to be kept with batch-number. (d) Inspectors may inspect the premises and plant and the process of manufacture and the means employed for standardising and testin'* and may take samples. (e) Any changes in the expert staff responsible and in the premises or plant to be reported. (/) Samples to be furnished on request. (g & h) Batches may be withheld from sale. (i) Licensee to comply with Barts III. and IV. and further requirements if necessary. PART III. Provisions with regard to names of substances and to containers, etc. 8*—If any substance is advertised or sold as a proprietary medicine or is contained in a medicine the 4 proper name ' of the substance shall appear on the label in the manner prescribed in this Bart of these Regulations. 9.—The substance is to be sealed in a previously sterilised glass container. (Ligatures and sutures may be in containers other than glass.) 10. - (1) Labelling. The following are required:— (a) The proper name of the substance in letters not less conspicuous than those in which the proprietary name, if any, is wnitten or printed, and following immediately after or under such pro¬ prietary name. (b) The number of the licence under which the substance is manu¬ factured preceded in the case of Import licenses by the words 4 Import License.' (c) A distinctive batch number. (d) The name and address of the maker, date of manufacture, and statements of toxicity if required, nature of antiseptic if any, are also enforced, also date of removal from cold storage at a temperature not exceeding 5° C. 11. —The sale of a substance after prescribed date is prohibited, but a practi¬ tioner may override this, if his attention has been drawn to the date and he is satisfied it is required by the urgency of the case.](https://iiif.wellcomecollection.org/image/b31361985_0001_1068.jp2/full/800%2C/0/default.jpg)
